TY - JOUR
T1 - Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy
T2 - Possible involvement of periostin
AU - Kobayashi, Yoshiyuki
AU - Yoshida, Shigeo
AU - Nakama, Takahito
AU - Zhou, Yedi
AU - Ishikawa, Keijiro
AU - Arita, Ryoichi
AU - Nakao, Shintaro
AU - Miyazaki, Masanori
AU - Sassa, Yukio
AU - Oshima, Yuji
AU - Izuhara, Kenji
AU - Kono, Toshihiro
AU - Ishibashi, Tatsuro
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Aim To determine whether CD163, a specific marker for M2 macrophages, is involved in the formation of preretinal fibrovascular membranes (FVMs) present in eyes with proliferative diabetic retinopathy (PDR). Methods We measured the levels of soluble (s)CD163, periostin and vascular endothelial growth factor by sandwich ELISA in vitreous samples from 74 eyes of 62 patients with PDR, 20 eyes of 18 patients with proliferative vitreoretinopathy, and 56 eyes of 54 patients with non-diabetic ocular diseases (control group). Immunohistochemical analyses were performed to determine the expressions of CD68, CD163 and periostin in the surgically resected FVMs and idiopathic epiretinal membranes (ERMs). Results The concentrations of sCD163 and periostin in the vitreous were significantly higher in patients with PDR than in non-diabetic controls (p<0.0001). There was a strong correlation between the vitreous concentrations of sCD163 and periostin. The mean vitreous level of sCD163 was significantly higher in eyes with FVMs than in those without FVMs (epicentre only). The number and percentage of CD163+ macrophages were significantly higher in the FVMs than in the idiopathic ERMs. Immunohistochemical analysis showed co-localisation of CD163 and periostin in FVM cells. Conclusions These findings indicate that the overexpression of CD163 by macrophages may be involved in the development of FVMs partly through periostin production.
AB - Aim To determine whether CD163, a specific marker for M2 macrophages, is involved in the formation of preretinal fibrovascular membranes (FVMs) present in eyes with proliferative diabetic retinopathy (PDR). Methods We measured the levels of soluble (s)CD163, periostin and vascular endothelial growth factor by sandwich ELISA in vitreous samples from 74 eyes of 62 patients with PDR, 20 eyes of 18 patients with proliferative vitreoretinopathy, and 56 eyes of 54 patients with non-diabetic ocular diseases (control group). Immunohistochemical analyses were performed to determine the expressions of CD68, CD163 and periostin in the surgically resected FVMs and idiopathic epiretinal membranes (ERMs). Results The concentrations of sCD163 and periostin in the vitreous were significantly higher in patients with PDR than in non-diabetic controls (p<0.0001). There was a strong correlation between the vitreous concentrations of sCD163 and periostin. The mean vitreous level of sCD163 was significantly higher in eyes with FVMs than in those without FVMs (epicentre only). The number and percentage of CD163+ macrophages were significantly higher in the FVMs than in the idiopathic ERMs. Immunohistochemical analysis showed co-localisation of CD163 and periostin in FVM cells. Conclusions These findings indicate that the overexpression of CD163 by macrophages may be involved in the development of FVMs partly through periostin production.
UR - http://www.scopus.com/inward/record.url?scp=84925402892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925402892&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2014-305321
DO - 10.1136/bjophthalmol-2014-305321
M3 - Article
C2 - 25281471
AN - SCOPUS:84925402892
SN - 0007-1161
VL - 99
SP - 451
EP - 456
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 4
ER -
